Cubist Systematic Strategies LLC Takes $883,000 Position in TriMas Co. (NASDAQ:TRS)

Cubist Systematic Strategies LLC acquired a new stake in TriMas Co. (NASDAQ:TRS - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 35,890 shares of the industrial products company's stock, valued at approximately $883,000. Cubist Systematic Strategies LLC owned approximately 0.09% of TriMas as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of TriMas by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 3,895,946 shares of the industrial products company's stock worth $95,801,000 after purchasing an additional 82,068 shares during the last quarter. Bank of America Corp DE grew its holdings in shares of TriMas by 127.3% in the 4th quarter. Bank of America Corp DE now owns 3,513,638 shares of the industrial products company's stock worth $86,400,000 after purchasing an additional 1,967,738 shares during the last quarter. Bellecapital International Ltd. bought a new stake in shares of TriMas in the 4th quarter worth about $29,160,000. Medina Value Partners LLC grew its holdings in shares of TriMas by 2.9% in the 4th quarter. Medina Value Partners LLC now owns 1,034,882 shares of the industrial products company's stock worth $25,448,000 after purchasing an additional 28,851 shares during the last quarter. Finally, Advisory Research Inc. grew its holdings in shares of TriMas by 41.2% in the 4th quarter. Advisory Research Inc. now owns 754,089 shares of the industrial products company's stock worth $18,543,000 after purchasing an additional 220,000 shares during the last quarter. Institutional investors and hedge funds own 99.42% of the company's stock.

Wall Street Analyst Weigh In

Separately, BWS Financial reissued a "buy" rating and set a $40.00 price objective on shares of TriMas in a report on Wednesday, April 30th.

TriMas Stock Down 0.0%

Shares of NASDAQ:TRS opened at $24.12 on Thursday. TriMas Co. has a 12 month low of $19.33 and a 12 month high of $28.51. The company's 50-day moving average price is $22.85 and its two-hundred day moving average price is $24.12. The company has a quick ratio of 1.44, a current ratio of 2.83 and a debt-to-equity ratio of 0.60. The firm has a market cap of $980.53 million, a P/E ratio of 37.69 and a beta of 0.58.

TriMas (NASDAQ:TRS - Get Free Report) last issued its quarterly earnings data on Tuesday, April 29th. The industrial products company reported $0.46 EPS for the quarter, topping analysts' consensus estimates of $0.43 by $0.03. TriMas had a net margin of 2.93% and a return on equity of 9.21%. The firm had revenue of $241.67 million for the quarter, compared to analyst estimates of $235.41 million. During the same quarter in the prior year, the firm earned $0.37 EPS. The company's revenue was up 6.4% on a year-over-year basis. As a group, research analysts forecast that TriMas Co. will post 1.69 EPS for the current fiscal year.

TriMas Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 13th. Shareholders of record on Tuesday, May 6th were issued a dividend of $0.04 per share. This represents a $0.16 dividend on an annualized basis and a yield of 0.66%. The ex-dividend date was Tuesday, May 6th. TriMas's dividend payout ratio is currently 20.78%.

Insider Activity

In other news, CFO Scott A. Mell sold 2,218 shares of the firm's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $22.54, for a total value of $49,993.72. Following the transaction, the chief financial officer now owns 26,288 shares of the company's stock, valued at approximately $592,531.52. This trade represents a 7.78% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Jeffrey A. Fielkow bought 2,500 shares of TriMas stock in a transaction dated Friday, February 28th. The stock was acquired at an average cost of $20.78 per share, for a total transaction of $51,950.00. Following the purchase, the director now directly owns 11,013 shares in the company, valued at approximately $228,850.14. The trade was a 29.37% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have acquired 929,729 shares of company stock valued at $22,280,897. 14.20% of the stock is currently owned by insiders.

TriMas Company Profile

TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Co. (NASDAQ:TRS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.